What is MEDIFAST INC (MED) stock price today?

MEDIFAST INC (MED) currently trades at $10.87 per share. The stock has a market capitalization of $118.70M and a P/E ratio of —x.

Is MED stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, MEDIFAST INC has a Smart Value Score of 45/100 (Grade C), resulting in a "Sell" investment rating. The Piotroski F-Score is 2/9 and Altman Z-Score is 5.46.

What is MEDIFAST INC's revenue and earnings?

MEDIFAST INC has trailing twelve-month (TTM) revenue of $385.79M with profit margins of -4.84%. Earnings per share (EPS) is $-1.70.

Is MEDIFAST INC financially healthy?

MEDIFAST INC's Piotroski F-Score is 2/9 (weak financial health). The Altman Z-Score of 5.46 places it in the safe zone.

MED

MEDIFAST INC

NYSE: MED · CONSUMER CYCLICAL · PERSONAL SERVICES

$10.87

-0.46% today

Updated 2026-04-30

Market cap

$118.70M

P/E ratio

—

P/S ratio

0.31x

EPS (TTM)

$-1.70

Dividend yield

—

52W range

$9 – $15

Volume

0.3M

Market cap

$118.70M

P/E ratio

—

P/S ratio

0.31x

EPS (TTM)

$-1.70

Dividend yield

—

52W range

$9 – $15

Volume

0.3M

WallStSmart proprietary scores

out of 100

Grade: C

Sell

Investment rating

2.0

Growth

6.0

Quality

2.0

Profitability

6.0

Valuation

2/9

Piotroski F-Score

Weak

5.5

Altman Z-Score

Safe zone

—

Industry rank

—

View all highly rated stocks (75+) →201 stocks currently score above 75

Price targets

Analyst target

$12.00

+10.40%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy0 Buy1 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Altman Z 5.46 — safe zone

Risks

- Piotroski 2/9 — weak financial health

- Thin margins at -4.84%

- Negative free cash flow $-6.63M

- Revenue declining -36.90% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$1.60B	$1.07B	$602.46M	$385.79M	$385.79M
Net income	$143.57M	$99.42M	$2.09M	$-18.67M	$-18.12M
EPS	—	—	—	—	$-1.70
Free cash flow	$177.89M	$141.17M	$17.02M	$1.25M	$-6.63M
Profit margin	8.98%	9.27%	0.35%	-4.84%	-4.84%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
MED	$118.70M	45	2.0	2.0	6.0	6.0	—	Hold
AMZN	$2.84T	59	6.7	6.5	3.3	6.0	-64.93%	Buy
TSLA	$1.41T	33	6.7	4.0	2.0	7.5	-43.10%	Avoid
BABA	$321.85B	50	4.0	6.0	8.0	5.8	+72.91%	Buy
HD	$321.53B	50	2.7	7.5	3.3	5.8	-35.55%	Hold
TM	$250.66B	53	5.3	5.0	6.3	5.0	—	Buy

Smart narrative

MEDIFAST INC trades at $10.87. Our Smart Value Score of 45/100 indicates the stock is fair. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of 5.46, it sits in the safe zone. TTM revenue stands at $385.79M. with profit margins at -4.84%.

Frequently asked questions

What is MEDIFAST INC's stock price?

MEDIFAST INC (MED) trades at $10.87.

Is MEDIFAST INC overvalued?

Smart Value Score 45/100 (Grade C, Sell).

What is the price target of MEDIFAST INC (MED)?

The analyst target price is $12.00, representing +10.4% upside from the current price of $10.87.

What is MEDIFAST INC's revenue?

TTM revenue is $385.79M.

Piotroski F-Score?

2/9 — weak financial health.

Altman Z-Score?

5.46 — safe zone.

Company info

SectorCONSUMER CYCLICAL

IndustryPERSONAL SERVICES

CountryUSA

ExchangeNYSE

CurrencyUSD

medifastinc.com

Quick metrics

P/S ratio0.31x

ROE-9.13%

Beta0.56

50D MA$10.42

200D MA$12.05

Shares out0.01B

Float0.01B

Short ratio—

Avg volume0.3M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

MED vs AMZN →MED vs TSLA →MED vs BABA →Stock screener →